{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:40:53Z","timestamp":1791330053218,"version":"4.3.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02868-7","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T04:00:34Z","timestamp":1755316834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Roles of inflammatory cytokines in the pathogenesis of hepatitis B virus-related acute-on-chronic liver failure and CAR-T therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhe","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"10","key":"2868_CR1","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-11-1920","volume":"18","author":"DW Lee","year":"2012","unstructured":"Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA. The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer. Clin Cancer Res. 2012;18(10):2780\u201390.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2868_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/cr.2016.154","volume":"27","author":"LA Johnson","year":"2017","unstructured":"Johnson LA, June CH. Driving gene-engineered T cell immunotherapy of cancer. Cell Res. 2017;27(1):38\u201358.","journal-title":"Cell Res"},{"issue":"5","key":"2868_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/bjh.14470","volume":"176","author":"RH Rouce","year":"2017","unstructured":"Rouce RH, Sharma S, Huynh M, Heslop HE. Recent advances in T-cell immunotherapy for haematological malignancies. Br J Haematol. 2017;176(5):688\u2013704.","journal-title":"Br J Haematol"},{"issue":"1","key":"2868_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","volume":"379","author":"CH June","year":"2018","unstructured":"June CH, Sadelain M. Chimeric antigen receptor therapy. N Engl J Med. 2018;379(1):64\u201373.","journal-title":"N Engl J Med"},{"issue":"12","key":"2868_CR5","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","volume":"119","author":"JN Kochenderfer","year":"2012","unstructured":"Kochenderfer JN, Dudley ME, Feldman SA, et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood. 2012;119(12):2709\u201320.","journal-title":"Blood"},{"issue":"2","key":"2868_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188\u201395.","journal-title":"Blood"},{"issue":"6","key":"2868_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","volume":"6","author":"DT Teachey","year":"2016","unstructured":"Teachey DT, Lacey SF, Shaw PA, et al. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016;6(6):664\u201379.","journal-title":"Cancer Discov"},{"issue":"22","key":"2868_CR8","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","volume":"36","author":"JN Brudno","year":"2018","unstructured":"Brudno JN, Maric I, Hartman SD, et al. T cells genetically modified to express an Anti-B-Cell maturation antigen chimeric antigen receptor cause remissions of Poor-Prognosis relapsed multiple myeloma. J Clin Oncol. 2018;36(22):2267\u201380.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2868_CR9","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","volume":"45","author":"JC Fitzgerald","year":"2017","unstructured":"Fitzgerald JC, Weiss SL, Maude SL, et al. Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia. Crit Care Med. 2017;45(2):e124\u201331.","journal-title":"Crit Care Med"},{"issue":"9959","key":"2868_CR10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053\u201363.","journal-title":"Lancet"},{"issue":"9859","key":"2868_CR11","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095\u2013128.","journal-title":"Lancet"},{"issue":"1","key":"2868_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.27795","volume":"62","author":"Y Shi","year":"2015","unstructured":"Shi Y, Yang Y, Hu YT, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 2015;62(1):232\u201342.","journal-title":"Hepatology"},{"key":"2868_CR13","doi-asserted-by":"publisher","first-page":"25487","DOI":"10.1038\/srep25487","volume":"6","author":"H Li","year":"2016","unstructured":"Li H, Chen LY, Zhang NN, et al. Characteristics, diagnosis and prognosis of Acute-on-Chronic liver failure in cirrhosis associated to hepatitis B. Sci Rep. 2016;6:25487.","journal-title":"Sci Rep"},{"issue":"15","key":"2868_CR14","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.12998\/wjcc.v10.i15.4717","volume":"10","author":"YY Zhang","year":"2022","unstructured":"Zhang YY, Meng ZJ. Definition and classification of acute-on-chronic liver diseases. World J Clin Cases. 2022;10(15):4717\u201325.","journal-title":"World J Clin Cases"},{"issue":"4","key":"2868_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1440-1746.2011.06971.x","volume":"27","author":"WK Seto","year":"2012","unstructured":"Seto WK, Lai CL, Yuen MF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol. 2012;27(4):662\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2868_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/17474124.2018.1426459","volume":"12","author":"RH Zhao","year":"2018","unstructured":"Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol. 2018;12(4):341\u201350.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"2868_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099\u2013108.","journal-title":"Hepatology"},{"issue":"2","key":"2868_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/liv.13504","volume":"38","author":"W Wu","year":"2018","unstructured":"Wu W, Yan H, Zhao H, et al. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: differentiate it from No-ACLF. Liver Int. 2018;38(2):248\u201357.","journal-title":"Liver Int"},{"issue":"4","key":"2868_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353\u201390.","journal-title":"Hepatol Int"},{"issue":"2","key":"2868_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","volume":"79","author":"EASL Clinical Practice","year":"2023","unstructured":"EASL Clinical Practice. Guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79(2):461\u201391.","journal-title":"J Hepatol"},{"issue":"1","key":"2868_CR21","first-page":"18","volume":"27","author":"F Liver","year":"2019","unstructured":"Liver F, Artificial Liver Group CS, o. I. D. CMA, Severe Liver D, Artificial Liver Group CS. o. H. C. M. A. Guideline for diagnosis and treatment of liver failure. Zhonghua Gan Zang Bing Za Zhi. 2019;27(1):18\u201326.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"12","key":"2868_CR22","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","volume":"67","author":"TZ Wu","year":"2018","unstructured":"Wu TZ, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus -related acute -on - chronic liver failure. Gut. 2018;67(12):2181\u201391.","journal-title":"Gut"},{"issue":"1","key":"2868_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/gutjnl-2020-323395","volume":"71","author":"J Li","year":"2022","unstructured":"Li J, Liang X, Jiang J. PBMC transcriptomics identifies immune-metabolism disorder during the development of. HBV-ACLF Gut. 2022;71(1):163\u201375.","journal-title":"HBV-ACLF Gut"},{"key":"2868_CR24","doi-asserted-by":"publisher","first-page":"615009","DOI":"10.3389\/fimmu.2020.615009","volume":"11","author":"A Fabri","year":"2020","unstructured":"Fabri A, Kandara K, Coudereau R, et al. Characterization of Circulating IL-10-Producing cells in septic shock patients: A proof of concept study. Front Immunol. 2020;11:615009.","journal-title":"Front Immunol"},{"issue":"3","key":"2868_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2249.2003.02376.x","volume":"135","author":"N Hyodo","year":"2004","unstructured":"Hyodo N, Nakamura I, Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol. 2004;135(3):462\u20136.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2868_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.14218\/JCTH.2015.00024","volume":"3","author":"T Lan","year":"2015","unstructured":"Lan T, Chang L, Wu L, Yuan YF. IL-6 plays a crucial role in HBV infection. J Clin Transl Hepatol. 2015;3(4):271\u20136.","journal-title":"J Clin Transl Hepatol"},{"issue":"30","key":"2868_CR27","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3748\/wjg.v26.i30.4479","volume":"26","author":"ZHOUC ZHANG","year":"2020","unstructured":"ZHANG ZHOUC, HE T T N, et al. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure[J]. World J Gastroenterol. 2020;26(30):4479\u201388.","journal-title":"World J Gastroenterol"},{"key":"2868_CR28","doi-asserted-by":"crossref","unstructured":"Wu Z-B, Zheng Y-B, Gao Z-L et al. Plasma Interleukin-6 level: A potential prognostic Indicator of emergent HBV-Associated ACLF. Can J Gastroenterol Hepatol 2021;11:20215545181.","DOI":"10.1155\/2021\/5545181"},{"key":"2868_CR29","doi-asserted-by":"publisher","first-page":"5545181","DOI":"10.1155\/2021\/5545181","volume":"2021","author":"ZB Wu","year":"2021","unstructured":"Wu ZB, Zheng YB, Wang K, et al. Plasma Interleukin-6 level: A potential prognostic Indicator of emergent HBV-Associated ACLF. Can J Gastroenterol Hepatol. 2021;2021:5545181.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"2868_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/liv.13504","volume":"38","author":"H-D Wei Wu","year":"2018","unstructured":"Wei Wu H-D. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: differentiate it from No-ACLF. Liver Int. 2018;38(2):248\u201357.","journal-title":"Liver Int"},{"key":"2868_CR31","doi-asserted-by":"publisher","first-page":"1133656","DOI":"10.3389\/fimmu.2023.1133656","volume":"14","author":"B Zhu","year":"2023","unstructured":"Zhu B, Gao F, Zhang Q, Wang X, et al. Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure. Front Immunol. 2023;14:1133656.","journal-title":"Front Immunol"},{"key":"2868_CR32","doi-asserted-by":"crossref","unstructured":"Wu Z B Wangk, Ye Y N et al. Plasma Interleukin-10: a likely predictive marker for hepatitis b virus-related acute-on-chronic liver failure[J]. Hepat Mon 2014;14(7):e19370.","DOI":"10.5812\/hepatmon.19370"},{"issue":"3","key":"2868_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","volume":"142","author":"V GARG","year":"2012","unstructured":"GARG V, GARG H. Granulocyte colony-stimulating factor mobilizes CD34 (+)cells and improves survival of patients with acute - on - chronic liver failure. Gastroenterology. 2012;142(3):505\u201312. e1.","journal-title":"Gastroenterology"},{"key":"2868_CR34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018;15:738\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2868_CR35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","volume":"150","author":"JJ Park","year":"2016","unstructured":"Park JJ, Wong DK, Wahed AS, et al. Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B. Gastroenterology. 2016;150(3):684\u2013e6955.","journal-title":"Gastroenterology"},{"issue":"1","key":"2868_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12985-017-0870-x","volume":"14","author":"S Gao","year":"2017","unstructured":"Gao S. Joshi ss,osiowy c,et al.chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants. Virol J. 2017;14(1):203.","journal-title":"Virol J"},{"key":"2868_CR37","first-page":"191A","volume":"68","author":"J Li","year":"2018","unstructured":"Li J, Chen X, Zhou XP, et al. Defining the molecular basis of hepatitis B virus-related acute-on-chronic liver failure by transcriptome sequencing of patient peripheral blood mononuclearcells. Hepatology. 2018;68:191A.","journal-title":"Hepatology"},{"issue":"10","key":"2868_CR38","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1097\/01.CCM.0000282072.56245.91","volume":"35","author":"E Abraham","year":"2007","unstructured":"Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007;35(10):2408\u201316.","journal-title":"Crit Care Med"},{"issue":"7","key":"2868_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12(7):387\u2013400.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"2868_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20042614","volume":"201","author":"A Tsung","year":"2005","unstructured":"Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201(7):1135\u201343.","journal-title":"J Exp Med"},{"issue":"1","key":"2868_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/taap.1995.1125","volume":"133","author":"M Blazka","year":"1995","unstructured":"Blazka M, Wilmer J, Holladay S, Wilson R, Luster M. Role of Proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 1995;133(1):43\u201352.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"2868_CR42","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/eji.200535261","volume":"36","author":"Y Ishida","year":"2006","unstructured":"Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N. Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminopheninduced acute liver injury. Eur J Immunol. 2006;36(4):1028\u201338.","journal-title":"Eur J Immunol"},{"issue":"1 Suppl","key":"2868_CR43","doi-asserted-by":"publisher","first-page":"s131","DOI":"10.1016\/j.jhep.2014.11.045","volume":"62","author":"V Arroyo","year":"2015","unstructured":"Arroyo V, Moreau R, Jalan R, et al. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. J Hepatol. 2015;62(1 Suppl):s131\u201343.","journal-title":"J Hepatol"},{"issue":"3","key":"2868_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","volume":"66","author":"R Hernaez","year":"2017","unstructured":"Hernaez R, Sola E, Moreau R, et al. Acute-on-chronic liver failure: an update. Gut. 2017;66(3):541\u201353.","journal-title":"Gut"},{"issue":"1","key":"2868_CR45","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41467-024-46047-8","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu X, Yang F, Zhang J,et, Al. BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4\u2009+\u2009T-cell exhaustion. Nat Commun. 2024;15(1):1835.","journal-title":"Nat Commun"},{"issue":"5","key":"2868_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jhep.2008.08.009","volume":"49","author":"JA ANTONIADES C G, BERRY P A, WENDON","year":"2008","unstructured":"ANTONIADES C G, BERRY P A, WENDON JA, et al. The importance of immune dysfunction in determining outcome in acute liver failure[J]. J Hepatol. 2008;49(5):845\u201361.","journal-title":"J Hepatol"},{"issue":"3","key":"2868_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V ARROYO","year":"2021","unstructured":"ARROYO V, ANGELI P, MOREAU R, et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis[J]. J Hepatol. 2021;74(3):670\u201385.","journal-title":"J Hepatol"},{"key":"2868_CR48","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","volume":"155","author":"Z Yao","year":"1995","unstructured":"Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995b;155:5483\u20136.","journal-title":"J Immunol"},{"issue":"5","key":"2868_CR49","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/biomedicines12051118","volume":"12","author":"Y Bai","year":"2024","unstructured":"Bai Y, Zhou R, Fan J, et al. A novel bifunctional fusion protein (Anti-IL-17A-sST2) protects against acute liver failure, modulating the TLR4\/MyD88 pathway and NLRP3 inflammasome activation. Biomedicines. 2024;12(5):1118.","journal-title":"Biomedicines"},{"key":"2868_CR50","doi-asserted-by":"publisher","first-page":"9140602","DOI":"10.1155\/2021\/9140602","volume":"2021","author":"NH Tan","year":"2021","unstructured":"Tan NH, Chen B, Du S, et al. Treg\/Th17 cell balance in patients with hepatitis B Virus-Related Acute-on-Chronic liver failure at different disease stages. Biomed Res Int. 2021;2021:9140602.","journal-title":"Biomed Res Int"},{"issue":"4","key":"2868_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/hep.20649","volume":"41","author":"JN Stoop","year":"2005","unstructured":"Stoop JN, van der Molen RG, Janssen HL, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology. 2005;41(4):771\u20138.","journal-title":"Hepatology"},{"issue":"7","key":"2868_CR52","first-page":"623","volume":"30","author":"GL Liu","year":"2014","unstructured":"Liu GL, Zhou XL, Tao P. The role of Th17 \/ Treg cell balance in the clinical outcome of hepatitis B virus -associated acute-on-chronic liver failure. Immunol J. 2014;30(7):623\u20137.","journal-title":"Immunol J"},{"issue":"2","key":"2868_CR53","first-page":"315","volume":"30","author":"H Zhang","year":"2011","unstructured":"Zhang H, Huang LX, Chen ZX, et al. Effect of CD4 (+) CD25(+)Foxp3 (+)regulatory T cells on acute -on-chronic liver failure caused by hepatitis B infection. J Southeast Univ (Med Sci Edi). 2011;30(2):315\u20138.","journal-title":"J Southeast Univ (Med Sci Edi)"},{"key":"2868_CR54","doi-asserted-by":"publisher","first-page":"1190379","DOI":"10.3389\/fimmu.2023.1190379","volume":"14","author":"D Shah","year":"2023","unstructured":"Shah D, Soper B, Shopland L. Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures. Front Immunol. 2023;14:1190379.","journal-title":"Front Immunol"},{"issue":"6","key":"2868_CR55","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","volume":"24","author":"M Norelli","year":"2018","unstructured":"Norelli M, Camisa B, Barbiera G, et al. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med. 2018;24(6):739\u201348.","journal-title":"Nat Med"},{"issue":"6","key":"2868_CR56","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","volume":"24","author":"T Giavridis","year":"2018","unstructured":"Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A, Sadelain M. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 Blockade. Nat Med. 2018;24(6):731\u20138.","journal-title":"Nat Med"},{"key":"2868_CR57","doi-asserted-by":"crossref","unstructured":"Xie YQ, Wenes M, Wang Y, Gao M, Hu X, Romero P et al. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol. 2024;42(11):1693\u20131704.","DOI":"10.1038\/s41587-023-02060-8"},{"key":"2868_CR58","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"H Guo","year":"2021","unstructured":"Guo H, Wang H, Yang H, et al. Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity. Nat Immunol. 2021;22:746\u201356.","journal-title":"Nat Immunol"},{"issue":"3","key":"2868_CR59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2024.02.003","volume":"31","author":"YW Huang","year":"2024","unstructured":"Huang YW, Wang HP. From suppressor to enhancer: IL-10\u2019s alternative role in CAR-T cell therapies against solid tumors. Cell Stem Cell. 2024;31(3):285\u20137.","journal-title":"Cell Stem Cell"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02868-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:27:13Z","timestamp":1757392033000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02868-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02868-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This single-center retrospective study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University [Ethical Approval No.: (2022) LEN Research Approval No. 089]. Written informed consent was obtained from all participants, with a waiver granted for deceased patients in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}